POSTER MINI Uretritis Gonore

7/30/2019 POSTER MINI Uretritis Gonore

1/26

URETHRITIS GONORRHEA

Herin Arini Natalia : C111 09 143

Dewi Siswantini : C111 09 138

Nur Fatminsari Almaidin : C111 09 272


2/26

Case Report Name : Mr. A

Age : 29 Years Old

Address : Regge II Makassar Date of admission : 9 10 2012

No. MR : 238851


3/26

Anamnesis Chief complaint : dysuria

Brief anamnesis :

Dysuria accompanied pus since 3weeks ago Fever since 3 weeks ago, higher at night

Malaise

Backbone and legs pain

Touch pain skin Sexual history + 2 months ago with not an official

partner, not use condoms


4/26

Present Status General condition : mild

Hygiene : moderate

Consciousness : composmentisVital signs :

BP : 110/60 mmHg

Pulse : 88x/min

RR : 18x/min

Temp : 36,5C


5/26

Dermatovenerology Location : external genitalia (OUE)

Size :

Efflorescence : OUE eritematous, oedema


6/26


7/26

Laboratory Result (19/7/2012)WBC : 6,3 x 103/ mm3

RBC : 5,26x106 mm3

Hb : 14,9 gr/dL Hct : 46,9%

LED/BBS : 15 mm/ 1 hour


8/26

ResumeA man, 29 years old, come to the hospital with chief

complaint of dysuria accompanied with pus since 3weeks ago. Fever since 3 weeks agom higher at night,malaise, backbone pain, touch pain skin


9/26

Diagnosis Urethritis gonorrhea


10/26

Therapy Rifampisin 600 mg/month 12 blister

DDS 100 mg/month and 100 mg/day 12 blister

Clofazimine 300 mg/month and 50 mg/day 12

blister For ENL reaction

Metilprednisolon 16 mg 1x2

Meloxicam 2x1 Vitamin B complex 3x1

Cetirizine 10 mg 2x1


11/26


12/26

Hansen's disease, is a chronic infectious diseasethat attacks the nervous system. This disease

can cause severe deformity of the feet, handsand face.

Discovered by Gerhard Armauer Hansen in1873.

LEPROSY/ HANSENS DISEASE


13/26

Leprosy is caused by a type of

bacteria calledMicrobacterium Leprae.

ETIOLOGY


14/26

M. leprae has low power of pathogenicinvasion, because patients that contain more

germs do not necessarily provide a more seversymptoms. The Unbalance between the degreeof infection with the degree of disease, causedby the different immune responses. Therefore

be called a disease of leprosy imunologicbecause clinical symptoms comparable to thelevel of cellular reactions.

Patogenesis


15/26

Numbness of skin lesions

Accompanied by thickening of nerve function

impairment BTA(+)

Cardinal sign


16/26

Sign on the skin

1. red skin patches

2.shiny skin

3. patches do not itch

4. skin lesions that do not sweat or hair

5. blisters are not painful

Clinical Symptoms


17/26

Sign on the nerve

1. tingling, or stabbing pain-pierced

2. movement disorders in the limbs or face

3. defect or deformity

4. ulcer that does not go away

Clinical Symptoms


18/26

Treating a case

with MDT


19/26

Multi Drug Therapy


20/26


21/26

How to manage complications


22/26

Leprosy reactions

Side-effects

Disabilities

Some patients may develop

complications


23/26

1 or 2 patients in 10 may develop reactions Reactions are not a side effect of MDT. They are the bodys

response to leprosy

More commonly seen in MB cases (more than 5 lesions)

Signs and symptoms include Skin: patch/s becomes reddish and/or swollen;

sometimes painful reddish nodules appear

Nerves: pain in the nerve and/or joint;loss of sensation and weakness of muscles (commonlyof hands, feet and around eyes)

General: fever, malaise, swelling of hands/feet

Leprosy reactions


24/26

Reactions which only involve the skin: rest and pain-killers are usually sufficient.

If there is no improvement within few days orworsening, then specific treatment is needed

Reactions which involves the nerves

start treatment with a course of corticosteroids (e.g.prednisolone) as soon as possible

will control all signs/symptoms of reaction

Managing reactions

S d f


25/26

40 mg (8 tablets) every morning for 14 days 30 mg (6 tablets) every morning for 14 days 20 mg (4 tablets) every morning for 14 days 15 mg (3 tablets) every morning for 14 days

10 mg (2 tablets) every morning for 14 days 5 mg (1 tablets) every morning for 14 days

Note: Continue rest and aspirin or paracetamol as required Examine the patient every 14 days before reducing the dose If there is no improvement or worsening, refer to hospital Continue MDT regularly

Suggested course of

prednisolone


26/26

Congratulate the patient Thank family/friends for their support Reassure that MDT completely cures leprosy

Any residual lesions will fade away slowly Show them how to protect anaesthetic areas and/or

disabilities Encourage to come back in case of any problem

Tell that they are welcome to bring other members offamily or friends for consultation Remove the patients name from the treatment register

When treatment is completed

POSTER MINI Uretritis Gonore

Documents

Transcript of POSTER MINI Uretritis Gonore